Public-registry trials using Rescue medication that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027) | Merck Sharp & Dohme LLC | Non-Muscle Invasive Bladder Cancer | PHASE1 / PHASE2 | 13 |
| First registered study | August 2001 — NCT00001016 (National Institute of Allergy and Infectious Diseases (NIAID)) |
| Registered studies matching this name | 694 all-time · 88 currently recruiting |
Source: ClinicalTrials.gov, the public trial registry.
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Trialed alongside
← Eichor home · All tracked trials · Non-Muscle Invasive Bladder Cancer studies · Weekly briefs